Atrial Flutter Ablation in the iCMR
NCT: NCT05904548 · RECRUITING
NCT IDNCT05904548
StatusRECRUITING
Start Date2024-06-20
Completion2026-12-31
Brief Summary
The VISABL-AFL clinical investigation is a prospective, single-arm, multi-center, interventional, Investigational Device Exemption (IDE) trial. The primary objectives of VISABL-AFL are to assess the safety and efficacy of radiofrequency (RF) ablation of type-I atrial flutter performed with the Vision-MR Ablation Catheter 2.0 in the iCMR environment.
Frequently Asked Questions
What is Atrial Flutter Ablation in the iCMR?
Atrial Flutter Ablation in the iCMR is a clinical trial registered under NCT05904548. Current status: RECRUITING.
What is the status of NCT05904548?
The current status of NCT05904548 (Atrial Flutter Ablation in the iCMR) is: RECRUITING.
When did Atrial Flutter Ablation in the iCMR start?
Atrial Flutter Ablation in the iCMR started on 2024-06-20.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.